C R Bard Newswire

C R Bard Newswire

Comprehensive Real-Time News Feed for C R Bard.

Results 1 - 20 of 436 in C R Bard

  1. C R Bard Inc (BCR) Downgraded by Zacks Investment Research to "Hold"Read the original story w/Photo

    20 hrs ago | AmericanBankingNews.com

    ... about the company. Jefferies Group LLC restated a "hold" rating and set a $237.00 price objective on shares of C R Bard in a report on Monday. Raymond James Financial, Inc. upgraded C R Bard from an "outperform" rating to a "strong-buy" rating and ...


  2. Investment Analysts' Downgrades for March, 28th (AFL, BCR, COLM,...Read the original story w/Photo

    21 hrs ago | AmericanBankingNews.com

    According to Zacks, "Aflac's top line remains exposed to a challenging operating environment, primarily in Japan. Moreover, low interest rates in Japan have led the company to change its business mix by deemphasizing the sales of first-sector products that carry higher premiums and are likely to stifle cash flows from the country.


  3. Soft Tissue Repair Global Market Research Sources, End user Analysis and Forecast to 2022Read the original story

    Yesterday | Emailwire.com

    ReportsWeb.com published 'Soft Tissue Repair Global Market' from its database. The report covers the market landscape and its growth prospects over the coming years.


  4. Analysts Set C R Bard Inc (BCR) Target Price at $245.55Read the original story w/Photo

    Monday | IntersportsWire

    C R Bard Inc has been assigned an average rating of "Buy" from the sixteen research firms that are covering the stock. Eight analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company.


  5. Jefferies Group LLC Reiterates Hold Rating for C R Bard IncRead the original story w/Photo

    Monday | AmericanBankingNews.com

    ... previous close. Several other analysts have also recently commented on BCR. Morgan Stanley upgraded shares of C R Bard from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $240.00 to $260.00 in a ...


  6. C R Bard Inc (BCR) Receives a oeHolda Rating from Jefferies Group LLCRead the original story w/Photo

    Monday | The Breeze

    Complete the form below to receive the latest headlines and analysts' recommendationsfor C R Bard Inc with our free daily email newsletter:


  7. Intact Vascular Announces Completion of Enrollment in the Tack...Read the original story

    Thursday Mar 23 | Customer Interaction Solutions

    A total of 210 patients have been enrolled in TOBA II at 33 sites in the U.S. and Europe. The TOBA II trial is a prospective, multi-center, two-arm, non-randomized study designed to investigate the safety and efficacy of the Tack Endovascular System in combination with standard or drug coated balloon angioplasty in the arteries above the knee.


  8. Europe Gelatin and Bone Glue Market Expected to Account for US $260.5 Mn by 2024-EndRead the original story w/Photo

    Wednesday Mar 22 | SBWire

    According to the latest market report published by Persistence Market Research titled 'Gelatin and Bone Glue Market: Europe Industry Analysis and Forecast ,' the Europe gelatin and bone glue market is expected to expand at a CAGR of 6.0% during the forecast period 2016-2024. Increasing number of trauma cases coupled with orthopedic surgeries and cardiovascular surgeries in developed nations is expected to fuel revenue growth of the Europe gelatin and bone glue market over the forecast period.


  9. Vascular Closure Device (VCD) Market Size & Forecast By Product, By...Read the original story w/Photo

    Monday Mar 20 | PR Newswire

    Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period. Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.


  10. FY2018 Earnings Forecast for C R Bard Inc Issued By William BlairRead the original story

    Friday Mar 17 | IntersportsWire

    Stock analysts at William Blair issued their FY2018 earnings estimates for C R Bard in a research report issued on Tuesday. William Blair analyst B. Weinstein forecasts that the firm will post earnings of $12.70 per share for the year.


  11. Characterizing and prognosticating chronic lymphocytic leukemia in...Read the original story w/Photo

    Wednesday Mar 15 | BioMed Central

    The ConnectA CLL registry is a multicenter, prospective observational cohort study, which enrolled 1494 adult patients between 2010-2014, at 199 US sites. Patients with CLL were enrolled within 2 months of initiating first line of therapy or a subsequent LOT showed that the improvement in overall survival noted in younger patients was less pronounced in the elderly [ Whether these differences are related to disparities in therapeutic choice, access to care, non-CLL-related deaths in elderly patients, or variations in CLL biology and prognostic indicators is unknown.


  12. 2017 Forecast - Soft Tissue Repair Global Market News, Industry Size, ...Read the original story w/Photo

    Thursday Mar 16 | SBWire

    New report on Soft tissues injuries involve damage to muscles, tendons and ligaments resulting in pain and inflammation. The soft tissue repair process is characterized by replacement of injured or destroyed tissues by healthy tissues.


  13. Dimensional Fund Advisors LP Raises Stake in C R Bard IncRead the original story w/Photo

    Thursday Mar 16 | IntersportsWire

    Dimensional Fund Advisors LP boosted its position in C R Bard Inc by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 235,925 shares of the company's stock after buying an additional 2,748 shares during the period.


  14. Brief-C R Bard Ceo Timothy Ring's Fy 2016 compensation $12.63 mln vs $11.74 mln in Fy 2015Read the original story w/Photo

    Wednesday Mar 15 | Reuters

    MEXICO CITY, March 15 Latin American currencies and stocks gained on Wednesday after the U.S. Federal Reserve hiked interest rates for the second time in three months, pointing to a benign economic outlook and a steady path of rate rises. After the rate move, Mexico's peso appreciated 2.25 percent versus the dollar, reaching its strongest level since U.S. President Donald Trump's election in November.


  15. Research Analysts Issue Forecasts for C R Bard Inc's FY2018 EarningsRead the original story w/Photo

    Wednesday Mar 15 | AmericanBankingNews.com

    Analysts at William Blair issued their FY2018 earnings per share estimates for shares of C R Bard in a note issued to investors on Tuesday. William Blair analyst B. Weinstein expects that the brokerage will post earnings of $12.70 per share for the year.


  16. Tip Location Devices Market to Witness Impressive Growth by 2016 - 2026Read the original story w/Photo

    Wednesday Mar 15 | SBWire

    This Future Market Insights report examines the 'Tip Location Devices Market' for the period 2016-2026. The primary objective of the report is to offer updates and in-depth analysis of market opportunities in the global tip location devices market.


  17. Bone Glue Market : New Business Opportunities & Investment Research Report 2026Read the original story w/Photo

    Wednesday Mar 15 | SBWire

    Bone Glue Market: Regional Overview North America accounts for almost half of the global bone glue market in terms of revenue. This is primarily due to the robust healthcare infrastructure and advanced pharmaceutical production in the U.S. However, Asia Pacific is expected to display the highest growth rate in the coming years.


  18. $8.3 Billion Biosurgery Technologies and Global Markets Report 2017Read the original story w/Photo

    Wednesday Mar 15 | GlobeNewswire

    Dublin, March 15, 2017 -- Research and Markets has announced the addition of the "Biosurgery: Technologies and Global Markets" report to their offering. The Global Biosurgery Market Should Reach $12.5 Billion by 2021 from $8.3 Billion in 2016 at a CAGR of 8.5% This report analyzes the market for products used to reduce excessive hemorrhage during surgery.


  19. Global Vascular Stents Market Sales Is Growing at 6.5% CAGR Till 2022Read the original story w/Photo

    Tuesday Mar 14 | SBWire

    Zion Market Research has published a new report titled " Vascular Stents Market : Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021". According to the report, global vascular stents market was valued at USD 2,907.1 million in 2015 and is expected to generate revenue of USD 4,230.0 million by end of 2021, growing at a CAGR of 6.5% between 2015 and 2021.


  20. Global Radiotherapy Market Analysis, Size, Share, Growth, Trends, and ForecastsRead the original story

    Monday Mar 13 | Emailwire.com

    Radiotherapy Market by Type, by Application, by Equipment Type, and by Region.The Global Radiotherapy Market was worth $5,450 million in 2016 and estimated to be growing at a CAGR of 6%, to reach $7,293 million by 2021 Global Radiotherapy Market , published is projected to reach USD 7,293 Million by 2021, at a CAGR of 6% from 2016 to 2021. Radiation therapy practices high energy radiation on directed cells and cell progression to stop them from growing and distributing.